source
- STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study showsAn experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.STAT · 15d ago↗ source
- FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientistA former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing their safetySTAT · 15d ago↗ source
- Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctorDeepfakes undermine the credibility that makes digital care — from telehealth visits to patient portals — possible.STAT · 15d ago